• Broxson, E.H., Dole, M., Wong, R., Laya, B.F. & Stork, L.C. (2001) Portal hypertension develops in a subset of children treated with maintenance oral 6 thioguanine for standard risk acute lymphoblastic leukemia. Blood, 98, 476a.
  • Erb, N., Harms, D.O. & Janka-Schaub, G. (1998) Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine. Cancer Chemotherapy and Pharmacology, 42, 266272.
  • Krivoy, N., Raz, R., Carter, A. & Alroy, G. (1982) Reversible hepatic veno-occlusive disease and 6-thioguanine. Annals of Internal Medicine, 96, 788.
  • Lancaster, D.L., Lennard, L., Rowland, K., Vora, A.J. & Lilleyman, J.S. (1998) Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations. British Journal of Haematology, 102, 439443.
  • Larrey, D., Freneaux, E., Berson, A., Babany, G., Degott, C., Valla, D., Pessayre, D. & Benhamou, J.P. (1988) Peliosis hepatis induced by 6-thioguanine administration. Gut, 29, 12651269.
  • Lennard, L. & Singleton, H.J. (1992) High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample. Journal of Chromatography, 583, 8390.
  • Lennard, L., Chew, T.S. & Lilleyman, J.S. (2001) Human thiopurine methyltransferase activity varies with red blood cell age. British Journal of Clinical Pharmacology, 52, 539546.
  • Lilleyman, J.S., Lennard, L., Rees, C.A., Morgan, G. & Maddocks, J.L. (1984) Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization. British Journal of Cancer, 49, 703707.
  • Vora, A.J., Mitchell, C.M., Kinsey, S., Richards, S., Eden, T., Lilleyman, J.S. & Lennard, L. (2002) Thioguanine-related veno-occlusive disease (VOD) of the liver in children with acute lymphoblastic leukaemia: Report from the United Kingdom Medical Research Council Trial ALL 97. Blood, 100, 126a.